VYNE Therapeutics Inc - VYNE - stock price prediction, stock price target, analyst ratings from 4 analysts

VYNE Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of 40.0%, and profit growth estimate of 1.1% for FY25, based on top 4 analyst calls.